Envestnet Portfolio Solutions, Inc. Neurocrine Biosciences Inc Transaction History
Envestnet Portfolio Solutions, Inc.
- $24.4 Billion
- Q2 2025
A detailed history of Envestnet Portfolio Solutions, Inc. transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Envestnet Portfolio Solutions, Inc. holds 3,273 shares of NBIX stock, worth $455,208. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,273
Previous 2,628
24.54%
Holding current value
$455,208
Previous $290,000
41.72%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding NBIX
# of Institutions
656Shares Held
101MCall Options Held
290KPut Options Held
214K-
Black Rock Inc. New York, NY14.2MShares$1.97 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.81MShares$1.36 Billion0.02% of portfolio
-
Dodge & Cox San Francisco, CA5.57MShares$774 Million0.42% of portfolio
-
State Street Corp Boston, MA4.47MShares$621 Million0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.09MShares$429 Million0.04% of portfolio
About NEUROCRINE BIOSCIENCES INC
- Ticker NBIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 95,639,296
- Market Cap $13.3B
- Description
- Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...